The multibillion-dollar market for intoxicating hemp products sold at gas stations, convenience stores, and smoke shops is about to become federally illegal. Congress has rewritten the legal definition of “hemp” to close the loophole that allowed delta-8, delta-10, THCA, HHC, and even delta-9 THC-infused edibles and beverages to be sold outside of state-licensed marijuana dispensaries.
Set to take effect on Nov. 12, 2026, the new law — the Continuing Appropriations and Extensions Act (the Extensions Act) — will reclassify the vast majority of today’s intoxicating hemp products as Schedule I marijuana under the Controlled Substances Act.
The backstory of the Extensions Act is important. The 2018 Farm Bill drew the line between legal hemp and illegal marijuana using one number — the delta-9 THC content had to be below 0.3% on a dry weight basis. But the Farm Bill said nothing about other cannabinoids like delta-8, delta-10, THCA, or HHC. Plus, manufacturers soon learned they could infuse beverages and gummies with intoxicating amounts of delta-9 THC that stayed under the .3% “dry weight” threshold. Entrepreneurs seized on these gaps, and a multi-billion-dollar industry of “legal” intoxicating hemp products filled convenience store shelves nationwide.
The 2026 Extensions Act addresses this scenario by replacing the definition of legalized hemp. The new law closes the gap in three key ways:
It shifts from a delta-9-only metric to “total THC,” which now includes THCA (tetrahydrocannabinolic acid) and any cannabinoid with similar intoxicating effects.
It sets a hard cap of 0.4 milligrams of total THC per retail container for finished hemp-derived consumer products.
It excludes cannabinoids not naturally produced by the plant or that are synthesized or manufactured — meaning synthetic and chemically converted cannabinoids are out.
The practical effect is straightforward: delta-8, delta-10, THCA flower, HHC, and most intoxicating edibles and beverages will be treated as illegal marijuana under the Controlled Substances Act — Schedule I — once the law takes effect. The 0.4 mg per-container cap by itself will render the vast majority of current intoxicating hemp edibles and beverages noncompliant.
One date, one rule. Until now, whether you could sell these products outside of state-licensed marijuana dispensaries depended on a complicated state-by-state analysis. For example, over 20 states permitted delta-8 with limited regulation and others had banned or restricted these products. After November 12, 2026, there will be a uniform federal restriction across the United States. Even if your state still technically permits certain products, selling them could violate federal law. Companies in this space should promptly consult legal counsel.
Revenue impact. For many gas stations, convenience stores, and smoke shops, intoxicating hemp products represent a meaningful and growing revenue category. Whether you are a regional chain with hundreds of locations or an independent operator with a handful of stores, these SKUs are likely contributing real margin. Losing them will require advance planning.
Legal exposure. Once these products become Schedule I federally, retailers who continue to sell them face potential criminal liability under federal law. Beyond that, potential plaintiffs may leverage consumer protection statutes and product liability claims against sellers of products that fall outside the federal definition of hemp after the effective date. In addition, existing state-licensed marijuana dispensaries could argue that non-licensed sellers of intoxicating hemp products are violating state unfair competition laws.
Insurance complications. Insurance carriers may reassess coverage for retailers who stock federally illegal products. Expect the possibility of new exclusions, premium increases, or reduced coverage on general and product liability policies.
Operators may wonder about the practicality of enforcement. The honest answer is that the enforcement picture is still developing. Even with the revised definition, the FDA and DEA have overlapping enforcement roles, and the Department of Justice’s priorities are influenced by resource constraints. There is precedent for this kind of prosecutorial restraint. In 2013, the Department of Justice issued what became known as the "Cole Memo," which deprioritized enforcement of the federal Controlled Substances Act against state-legal cannabis businesses so long as cannabis from legal states was not being trafficked to other states.
Although the Cole Memo was rescinded in January 2018, it illustrates that federal authorities have previously chosen to exercise discretion rather than broadly enforce against an entire category of activity. It is possible that Congress or the Department of Justice could take a similar approach with respect to federally illegal hemp products, particularly if states continue to develop their own regulatory frameworks.
There are also technical gray areas that need to be resolved. This includes how “total THC” is calculated, how THCA is measured after decarboxylation (heating), what “dry weight” means for processed products like beverages and gummies, and which lab methodologies are accepted. Much of this will depend on forthcoming FDA guidance and standardized procedures.
That said, uncertainty about enforcement is not a business strategy. The law will be on the books. Regardless of what enforcement looks like on day one, the legal classification itself creates downstream risk, from private lawsuits to regulatory considerations to banking complications to insurance coverage gaps.
Do not assume you can wait for November 2026 to act. Some state and local governments are moving ahead of the federal timeline. For example, Ohio has already enacted a ban on the manufacture of sale of intoxicating hemp products, which went into effect in March 2026. Local carve-outs may not align with the federal 0.4 mg per-container cap, compounding the compliance puzzle. This is likely a preview of what will happen across the country. Operators in multiple jurisdictions should track local developments closely, because local restrictions could hit before, and potentially differ from, the federal rules.
Yes — there is an active effort to push back the effective date. Several bills and amendments have been introduced to Congress to delay or alter the upcoming federal ban. These include, among others:
Hemp Planting Predictability Act. Bipartisan legislation that seeks to delay the implementation of the restrictive hemp policies and THC caps until November 2028. The primary goal of this Act is to provide businesses and farmers with a transitional grace period. Notably this Act does not change the substance of the ban itself, but rather delays enforcement.
Hemp Safety Enforcement Act. Seeks to amend the Agricultural Marketing Act of 1946 to create a state and tribal opt-out mechanism from the federal hemp regulatory framework. The bill, designed to take effect at the same time as the Appropriations Bill, would operate alongside the impending definitional change of hemp. Under this Act, a state or tribal jurisdiction may file a notice with the USDA opting out of the federal definition of hemp and substitute its own definition, subject to certain caveats.
As of now, however, the ban is poised to become effective Nov. 12, 2026. That is the current state of the law. A delay is possible but not certain. Plan for the ban while watching for legislative movement.
Whether you are a large chain or a single-location operator, there are several steps your business should take ahead of the upcoming ban.
Inventory your affected SKUs. Identify every delta-8, delta-9, delta-10, THCA flower, HHC, and intoxicating cannabis edible or beverage product across your locations and estimate the revenue at risk so leadership can plan accordingly.
Talk to suppliers and distributors now. Ask about sell-through timelines, return or buy-back rights, and whether they are developing compliant reformulated products such as truly non-intoxicating CBD items that will remain legal.
Plan your inventory drawdown. You do not want to be holding soon-to-be-Schedule-I product on November 12, 2026. Work backward from that date to set purchase and reorder cutoffs.
Review vendor contracts. Work with counsel to review contracts with respect to indemnification clauses, compliance representations, and recall or return provisions. If your agreements are silent on regulatory changes, negotiate protective language now.
Check your insurance. Talk to your broker about how a return to federal illegality could affect general liability and product liability coverage. Expect possible exclusions, higher premiums, or coverage gaps.
Monitor federal and local developments. The Hemp Planting Predictability Act bill could push the effective date to 2028. Meanwhile, local ordinances may move faster and differ from federal limits. Stay plugged in
Train your people. Store managers and clerks need to know what is changing. Update point-of-sale systems, age-gating protocols, and signage well before the deadline.
Consult legal counsel. The shift from a state-by-state analysis to a uniform federal restriction is significant. Get advice specific to your operations before the effective date arrives.
The era of broadly available intoxicating hemp at retail stores outside of state-licensed marijuana dispensaries is ending at the federal level. The Extensions Act draws a clear line: products exceeding the 0.4 mg total THC per-container cap, products containing synthetic or chemically converted cannabinoids, and products marketed for intoxicating effects will no longer fit within the legal definition of hemp.
For operators of businesses that sell intoxicating hemp products, the smart move is to get ahead of the transition now, assess the financial impact, plan your inventory strategy, protect yourself contractually, and stay plugged into legislative developments. The operators who start planning today will be the ones best positioned when November 2026 arrives.
William Bogot is a Partner in the Chicago office of Fox Rothschild, a national law firm, and Co-Chair of the firm’s Cannabis Law Practice Group. Akshay Krishnamani is an Associate in Fox Rothschild’s Chicago office and a member of the Cannabis Law Practice Group.
